Brief: Caris Life Sciences Enters New Credit Agreement With Blue Owl Capital And Blackstone - SEC Filing
02/04/2026 22:31
April 2 (Reuters) - Caris Life Sciences Inc CAI.O: CARIS LIFE SCIENCES INC - ENTERS NEW CREDIT AGREEMENT WITH BLUE OWL CAPITAL AND BLACKSTONE - SEC FILING CARIS LIFE SCIENCES INC - CREDIT AGREEMENT INCLUDES $400 MILLION TERM LOAN, $300 MILLION DELAYED DRAW, $500 MILLION INCREMENTAL FACILITY - SEC FILING CARIS LIFE SCIENCES INC - INITIAL TERM FACILITY MATURES IN APRIL 2031; DELAYED DRAW AVAILABLE THROUGH AUGUST 2027 - SEC FILING Source text: [ID:n0002019410-26-000019] Further company coverage: CAI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caris Life Sciences
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Caris Life Sciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Caris Life Sciences Q2 revenue rises 45% on the back of molecular profiling services
Caris Life Sciences Inc expected to post earnings of 1 cent a share - Earnings Preview
Caris Life Sciences Q1 revenue rises on demand for molecular profiling services